Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 22912795)

1.

HIV-1 RNA may decline more slowly in semen than in blood following initiation of efavirenz-based antiretroviral therapy.

Graham SM, Holte SE, Dragavon JA, Ramko KM, Mandaliya KN, McClelland RS, Peshu NM, Sanders EJ, Krieger JN, Coombs RW.

PLoS One. 2012;7(8):e43086. doi: 10.1371/journal.pone.0043086. Epub 2012 Aug 13.

2.

Higher concentration of HIV RNA in rectal mucosa secretions than in blood and seminal plasma, among men who have sex with men, independent of antiretroviral therapy.

Zuckerman RA, Whittington WL, Celum CL, Collis TK, Lucchetti AJ, Sanchez JL, Hughes JP, Sanchez JL, Coombs RW.

J Infect Dis. 2004 Jul 1;190(1):156-61. Epub 2004 Jun 9.

3.

Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection.

Gay CL, Mayo AJ, Mfalila CK, Chu H, Barry AC, Kuruc JD, McGee KS, Kerkau M, Sebastian J, Fiscus SA, Margolis DM, Hicks CB, Ferrari G, Eron JJ; Duke-UNC Acute HIV Infection Consortium.

AIDS. 2011 Apr 24;25(7):941-9. doi: 10.1097/QAD.0b013e3283463c07.

4.

Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248.

Andrade A, Rosenkranz SL, Cillo AR, Lu D, Daar ES, Jacobson JM, Lederman M, Acosta EP, Campbell T, Feinberg J, Flexner C, Mellors JW, Kuritzkes DR; AIDS Clinical Trials Group A5248 Team.

J Infect Dis. 2013 Sep;208(6):884-91. doi: 10.1093/infdis/jit272. Epub 2013 Jun 24.

5.

Differential effects of efavirenz, lopinavir/r, and atazanavir/r on the initial viral decay rate in treatment naïve HIV-1-infected patients.

Edén A, Andersson LM, Andersson O, Flamholc L, Josephson F, Nilsson S, Ormaasen V, Svedhem V, Säll C, Sönnerborg A, Tunbäck P, Gisslén M.

AIDS Res Hum Retroviruses. 2010 May;26(5):533-40. doi: 10.1089/aid.2009.0177.

PMID:
20455766
6.

Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.

Graham SM, Holte SE, Peshu NM, Richardson BA, Panteleeff DD, Jaoko WG, Ndinya-Achola JO, Mandaliya KN, Overbaugh JM, McClelland RS.

AIDS. 2007 Feb 19;21(4):501-7.

PMID:
17301569
7.

Impact of antiretroviral therapy duration and intensification on isolated shedding of HIV-1 RNA in semen.

Osborne BJ, Sheth PM, Yi TJ, Kovacs C, Benko E, Porte Cl, Huibner S, Le AQ, Danroth R, Baraki B, Mazzulli T, Brumme ZL, Kaul R.

J Infect Dis. 2013 Apr 15;207(8):1226-34. doi: 10.1093/infdis/jit026. Epub 2013 Jan 17.

8.
9.

Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission.

Tachet A, Dulioust E, Salmon D, De Almeida M, Rivalland S, Finkielsztejn L, Heard I, Jouannet P, Sicard D, Rouzioux C.

AIDS. 1999 May 7;13(7):823-31.

PMID:
10357382
10.

Effect of antiviral treatment on the shedding of HIV-1 in semen.

Vernazza PL, Gilliam BL, Flepp M, Dyer JR, Frank AC, Fiscus SA, Cohen MS, Eron JJ.

AIDS. 1997 Aug;11(10):1249-54.

PMID:
9256943
11.

HIV dynamics in seminal plasma during primary HIV infection.

Stekler J, Sycks BJ, Holte S, Maenza J, Stevens CE, Dragavon J, Collier AC, Coombs RW.

AIDS Res Hum Retroviruses. 2008 Oct;24(10):1269-74. doi: 10.1089/aid.2008.0014.

12.

Nucleoside analogues achieve high concentrations in seminal plasma: relationship between drug concentration and virus burden.

Pereira AS, Kashuba AD, Fiscus SA, Hall JE, Tidwell RR, Troiani L, Dunn JA, Eron JJ Jr, Cohen MS.

J Infect Dis. 1999 Dec;180(6):2039-43.

13.

The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy.

Sadiq ST, Taylor S, Copas AJ, Bennett J, Kaye S, Drake SM, Kirk S, Pillay D, Weller IV.

Sex Transm Infect. 2005 Apr;81(2):120-3.

14.

Persistent HIV type 1 infection in semen and blood compartments in patients after long-term potent antiretroviral therapy.

Craigo JK, Patterson BK, Paranjpe S, Kulka K, Ding M, Mellors J, Montelaro RC, Gupta P.

AIDS Res Hum Retroviruses. 2004 Nov;20(11):1196-209.

PMID:
15588342
15.

Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study.

Vernazza PL, Troiani L, Flepp MJ, Cone RW, Schock J, Roth F, Boggian K, Cohen MS, Fiscus SA, Eron JJ.

AIDS. 2000 Jan 28;14(2):117-21.

PMID:
10708281
16.

Assisted reproduction in HIV-1-serodifferent couples: the need for viral validation of processed semen.

Leruez-Ville M, de Almeida M, Tachet A, Dulioust E, Guibert J, Mandelbrot L, Salmon D, Jouannet P, Rouzioux C.

AIDS. 2002 Nov 22;16(17):2267-73.

PMID:
12441798
17.

Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration.

Watanabe D, Ibe S, Uehira T, Minami R, Sasakawa A, Yajima K, Yonemoto H, Bando H, Ogawa Y, Taniguchi T, Kasai D, Nishida Y, Yamamoto M, Kaneda T, Shirasaka T.

BMC Infect Dis. 2011 May 24;11:146. doi: 10.1186/1471-2334-11-146.

18.

Longitudinal comparison between plasma and seminal HIV-1 viral loads during antiretroviral treatment.

Pinto Neto LF, Vieira NF, Soprani M, Cunha CB, Cabral VP, Dietze R, Ribeiro-Rodrigues R.

Rev Soc Bras Med Trop. 2003 Nov-Dec;36(6):689-94. Epub 2004 Feb 17.

19.

Poor efficacy and tolerability of stavudine, didanosine, and efavirenz-based regimen in treatment-naive patients in Senegal.

Canestri A, Sow PS, Vray M, Ngom F, M'boup S, Kane CT, Delaporte E, Gueye M, Peytavin G, Girard PM, Landman R; ANRS 12-06/IMEA 012 Trial Study Group.

MedGenMed. 2007 Oct 9;9(4):7.

20.

Asymptomatic urethritis and detection of HIV-1 RNA in seminal plasma.

Winter AJ, Taylor S, Workman J, White D, Ross JD, Swan AV, Pillay D.

Sex Transm Infect. 1999 Aug;75(4):261-3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk